HELX Fees and Costs — Franklin Genomic Advancements ETF
Data updated: 2026-08-27
The net expense ratio is 0.50%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $2K in broker commissions, 0.0095% of average net assets, and portfolio turnover was 29%.
HELX Fees and Expenses
Annual operating expenses and sales charges of HELX. Prospectus, as of March 31, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.50% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.50% |
| Fee waiver | — |
| Net expense ratio | 0.50% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
HELX Costs Over Time
On $10,000 invested in HELX, assuming 5% a year before costs, total costs come to $322 over 5 years, cutting the return by 0.53% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.50%) | $52 | $165 | $287 |
| Trading costs (broker commissions) | $1 | $3 | $5 |
| Lost growth on money paid in costs | $0 | $8 | $29 |
| Total costs | $53 | $176 | $322 |
| Value after costs | $10,447 | $11,400 | $12,441 |
| Impact on return, per year | 0.53% | 0.53% | 0.53% |
HELX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0095%
- Total broker commissions: $2K
- Bought from dealers (principal trades, not a cost): $7.3M
- Portfolio turnover (prospectus): 29%
- Securities lending: none during the year
HELX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| CitiGroup Global Markets Inc. | $185 | 16.78% |
| JEFFERIES LLC | $164 | 14.93% |
| PIPER SANDLER & CO. | $130 | 11.85% |
| INSTINET LLC | $119 | 10.79% |
| J.P. Morgan Securities LLC | $105 | 9.52% |
| RBC CAPITAL MARKETS, LLC | $102 | 9.25% |
| SG AMERICAS SECURITIES LLC | $89 | 8.08% |
| ROBERT W. BAIRD & CO. INC. | $76 | 6.95% |
| TD SECURITIES (USA) LLC | $71 | 6.50% |
| WELLS FARGO SECURITIES, LLC | $59 | 5.35% |
HELX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $4.5M | 61.93% |
| Macquarie Capital (USA) Inc. | $1.5M | 20.46% |
| CitiGroup Global Markets Inc. | $1.3M | 17.61% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.